132 related articles for article (PubMed ID: 16303829)
1. Commentary: the PROactive study--the glass is half full.
Fonseca V; Jawa A; Asnani S
J Clin Endocrinol Metab; 2006 Jan; 91(1):25-7. PubMed ID: 16303829
[No Abstract] [Full Text] [Related]
2. [The PPARgamma receptor agonists and prevention of cardio-vascular complications in patients with type 2 diabetes. The results of the PROactive study].
Szymborska-Kajanek A; Strojek K
Kardiol Pol; 2006 Mar; 64(3):322-5; discussion 325-6. PubMed ID: 16583340
[No Abstract] [Full Text] [Related]
3. [Glitazones critically evaluated].
Schernthaner G
Dtsch Med Wochenschr; 2007 Dec; 132(49):2619. PubMed ID: 18050024
[No Abstract] [Full Text] [Related]
4. [The effects of thiazolidinedione from the cardiologic viewpoint].
Ziegler R
Med Monatsschr Pharm; 2005 Oct; 28(10):365. PubMed ID: 16245456
[No Abstract] [Full Text] [Related]
5. The PROactive study: some answers, many questions.
Yki-Järvinen H
Lancet; 2005 Oct; 366(9493):1241-2. PubMed ID: 16214581
[No Abstract] [Full Text] [Related]
6. [Pioglitazone protects the type-2-diabetes patient from myocardial infarction and stroke].
MMW Fortschr Med; 2007 Aug; 149(31-32):52-3. PubMed ID: 17849787
[No Abstract] [Full Text] [Related]
7. Implications of rosiglitazone and pioglitazone on cardiovascular risk in patients with type 2 diabetes mellitus.
Irons BK; Greene RS; Mazzolini TA; Edwards KL; Sleeper RB
Pharmacotherapy; 2006 Feb; 26(2):168-81. PubMed ID: 16466323
[TBL] [Abstract][Full Text] [Related]
8. Thiazolidinediones.
Yki-Järvinen H
N Engl J Med; 2004 Sep; 351(11):1106-18. PubMed ID: 15356308
[No Abstract] [Full Text] [Related]
9. The Avandia debate: an unhappy conclusion.
Bloomgarden Z; Handelsman Y
J Diabetes; 2010 Dec; 2(4):221-2. PubMed ID: 20923505
[No Abstract] [Full Text] [Related]
10. Implications of thiazolidinedione use and cardiovascular risk: is it all about the sugar?
Krantz MJ
Pharmacotherapy; 2006 Jul; 26(7):1049; discussion 1049-50. PubMed ID: 16803430
[No Abstract] [Full Text] [Related]
11. PROactive in patients with type 2 diabetes and previous myocardial infarction: swinging the sword of Damocles?
Westerbacka J
J Am Coll Cardiol; 2007 May; 49(17):1781-2. PubMed ID: 17466228
[No Abstract] [Full Text] [Related]
12. [Too positive comment on glitazones].
Lindberg M
Ugeskr Laeger; 2007 Feb; 169(8):733; author reply 733. PubMed ID: 17338040
[No Abstract] [Full Text] [Related]
13. [Trial of pioglitazone for the secondary prevention of cardiovascular events in patients with diabetes mellitus type 2: insufficient evidence].
Holleman F; Gerdes VE; de Vries JH; Hoekstra JB
Ned Tijdschr Geneeskd; 2006 Feb; 150(7):358-60. PubMed ID: 16523797
[TBL] [Abstract][Full Text] [Related]
14. Outlook on diabetes drug less than rosy. Early work suggests that rosiglitazone (Avandia) may not be best for the heart.
Harv Heart Lett; 2007 Aug; 17(12):1-2. PubMed ID: 17717888
[No Abstract] [Full Text] [Related]
15. [Warning signals insulin resistance. Insulin resistance causes not only diabetes].
MMW Fortschr Med; 2004 Jul; 146(29-30):49. PubMed ID: 15540564
[No Abstract] [Full Text] [Related]
16. Cardiovascular effects of thiazolidinediones: a review of the literature.
Acharya D; Falik R
South Med J; 2009 Jan; 102(1):51-6. PubMed ID: 19077768
[TBL] [Abstract][Full Text] [Related]
17. [Glitazones more than hypoglycemics in type 2 diabetes].
Sjöholm A
Lakartidningen; 2007 Oct 24-30; 104(43):3201-3. PubMed ID: 18018938
[No Abstract] [Full Text] [Related]
18. PROactive study.
Guillausseau PJ
Lancet; 2006 Jan; 367(9504):23; author reply 26-7. PubMed ID: 16399140
[No Abstract] [Full Text] [Related]
19. Pleiotropic effects of thiazolidinediones: implications for the treatment of patients with type 2 diabetes mellitus.
Defronzo RA; Mehta RJ; Schnure JJ
Hosp Pract (1995); 2013 Apr; 41(2):132-47. PubMed ID: 23680744
[TBL] [Abstract][Full Text] [Related]
20. Thiazolidinediones in type 2 diabetes: a cardiology perspective.
Khanderia U; Pop-Busui R; Eagle KA
Ann Pharmacother; 2008 Oct; 42(10):1466-74. PubMed ID: 18698014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]